Inventor · disambiguated record
Karl E. Hellstrom
Also filed as: HELLSTROEM KARL E · HELLSTROEM KARL ERIK · HELLSTROM KARL E · HELLSTROM KARL-ERIK
34 granted patents·14 pending applications·2,345 citations·filing 1984–2020
98Inventor score
Files withONCOGEN20BRISTOL MYERS SQUIBB CO11PACIFIC NORTHWEST RES INST4HELLSTROM KARL ERIK2PACIFIC NORTHWEST DIABETES RES INSTITUTE2
Top patents by PatentIndex Score
48 records- 0196US5171665AMonoclonal antibody to novel antigen associated with human tumorsONCOGEN·Filed 1989·Granted Dec 15, 1992·211 cites·24 claims
- 0295US5869045AAntibody conjugates reactive with human carcinomasBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Feb 9, 1999·402 cites·7 claims
- 0395US5134075AMonoclonal antibody to novel antigen associated with human tumorsONCOGEN·Filed 1989·Granted Jul 28, 1992·143 cites·21 claims
- 0495US5091178ATumor therapy with biologically active anti-tumor antibodiesONCOGEN·Filed 1990·Granted Feb 25, 1992·158 cites·3 claims
- 0595US4918164ATumor immunotherapy using anti-idiotypic antibodiesONCOGEN·Filed 1987·Granted Apr 17, 1990·132 cites·14 claims
- 0694US6770445B1Methods and compositions for diagnosing carcinomasPACIFIC NORTHWEST RES INST·Filed 2000·Granted Aug 3, 2004·78 cites·3 claims
- 0793US5262177ARecombinant viruses encoding the human melanoma-associated antigenONCOGEN·Filed 1987·Granted Nov 16, 1993·123 cites·34 claims
- 0892US5811098AAntibodies to HER4, human receptor tyrosine kinaseBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Sep 22, 1998·123 cites·17 claims
- 0990US4997913ApH-sensitive immunoconjugates and methods for their use in tumor therapyONCOGEN·Filed 1987·Granted Mar 5, 1991·68 cites·25 claims
- 1089US5980896AAntibodies reactive with human carcinomasBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Nov 9, 1999·104 cites·35 claims
- 1188US4935495AMonoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomasONCOGEN·Filed 1984·Granted Jun 19, 1990·45 cites·16 claims
- 1287US4906562AMonocolonal antibodies and antigen for human non-small cell lung carcinomasONCOGEN·Filed 1985·Granted Mar 6, 1990·61 cites·28 claims
- 1386US5354847AChimeric antibody with specificity to human tumor antigenBRISTOL MYERS SQUIBB CO·Filed 1991·Granted Oct 11, 1994·77 cites·4 claims
- 1486US5091177AMonoclonal antibodies for treatment of human non-small cell lung carcinomasONCOGEN·Filed 1990·Granted Feb 25, 1992·59 cites·33 claims
- 1585US5491088AMonoclonal antibody BR 96 and chimeric monoclonal antibodies having the variable region of MAB BR96, which bind to a variant of ley antigen on human carcimona cellsONCOGEN·Filed 1993·Granted Feb 13, 1996·63 cites·12 claims
- 1685US5242824AMonoclonal antibody to human carcinomasONCOGEN·Filed 1989·Granted Sep 7, 1993·69 cites·8 claims
- 1784US7547681B2Surface receptor antigen vaccinesUNIV WASHINGTON·Filed 2004·Granted Jun 16, 2009·12 cites·11 claims
- 1884US6734172B2Surface receptor antigen vaccinesPACIFIC NORTHWEST RES INST·Filed 1999·Granted May 11, 2004·60 cites·7 claims
- 1984US4737579AMonoclonal antibodies for human non-small cell lung carinomasONCOGEN·Filed 1986·Granted Apr 12, 1988·35 cites·24 claims
- 2083US5840854AMonoclonal antibody BR110 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Nov 24, 1998·54 cites·22 claims
- 2177US5165922ASynergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapyBRISTOL MYERS SQUIBB CO·Filed 1990·Granted Nov 24, 1992·58 cites·2 claims
- 2276US5597707ATumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their useBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jan 28, 1997·41 cites·13 claims
- 2375US5185432AMonoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomasONCOGEN·Filed 1986·Granted Feb 9, 1993·19 cites·18 claims
- 2475US5141742AVaccines against melanomaONCOGEN·Filed 1991·Granted Aug 25, 1992·48 cites·16 claims
- 2571US5614610ATumor immunotherapy using anti-idiotypic antibodiesONCOGEN·Filed 1988·Granted Mar 25, 1997·19 cites·5 claims
- 2664US6020145AMethods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96BRISTOL MYERS SQUIBB CO·Filed 1994·Granted Feb 1, 2000·17 cites·4 claims
- 2763US9822169B2Compositions and methods of use for determination of HE4aHELLSTROM INGEGERD·Filed 2011·Granted Nov 21, 2017·1 cites·6 claims
- 2862US6183734B1Inhibition of tumor cell growth by administration of B7-transfected cellsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Feb 6, 2001·22 cites·9 claims
- 2962US2009104684A1Diagnosis of carcinomasPACIFIC NORTHWEST RES INST·Filed 2007·Application pending·0 cites
- 3060US2018217158A1Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cellsUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2018·Application pending·0 cites
- 3156US7745159B2Methods and compositions for diagnosing carcinomasSCHOLLER NATHALIE B·Filed 2004·Granted Jun 29, 2010·3 cites·27 claims
- 3255US2020325215A1COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4aPACIFIC NORTHWEST DIABETES RES INSTITUTE·Filed 2020·Application pending·0 cites
- 3352US5055559AAnti-melanoma antibody MG-21 for diagnosis and therapy of human tumorsONCOGEN·Filed 1986·Granted Oct 8, 1991·13 cites·4 claims
- 3452US2013224772A1Method for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cellsHELLSTROM KARL ERIK·Filed 2011·Application pending·0 cites
- 3551US2006018914A1Novel antibody conjugates reactive with human carcinomasBRISTOL MYERS SQUIBB CO·Filed 2005·Application pending·0 cites
- 3650US2018057575A1COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4aPACIFIC NORTHWEST DIABETES RES INSTITUTE·Filed 2017·Application pending·0 cites
- 3750US2009042224A1Methods for diagnosis and/or prognosis of ovarian cancerUNIV WASHINGTON·Filed 2008·Application pending·0 cites
- 3849US2003219436A1Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion proteinFiled 2002·Application pending·0 cites
- 3949US2004058445A1Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BBFiled 2002·Application pending·0 cites
- 4048US2004043029A1Novel antibodies reactive with human carcinomasBRISTOL MYERS SQUIBB CO·Filed 2003·Application pending·0 cites
- 4143US2011300186A1Functionalized Nano- and Micro-materials for Medical TherapiesHELLSTROM KARL ERIK·Filed 2011·Application pending·0 cites
- 4243US2002192223A1Novel antibody conjugates reactive with human carcinomasFiled 2001·Application pending·0 cites
- 4342US5084560AImmunoconjugates and methods for their use in tumor therapyONCOGEN·Filed 1990·Granted Jan 28, 1992·13 cites·10 claims
- 4442US2007286860A1Compositions and Methods for Inducing Anti-Tumor ImmunityWASHINGTON RES FOUND·Filed 2005·Application pending·0 cites
- 4541US5411884AMonoclonal antibody L53 which recognizes a human tumor-associated antigenONCOGEN·Filed 1993·Granted May 2, 1995·8 cites·13 claims
- 4640US2011104675A1Methods and Compositions for Diagnosing CarcinomasPACIFIC NORTHWEST RES INST·Filed 2010·Application pending·0 cites
- 4737US5766588ATumor immunotherapy using anti-idiotypic antibodiesONCOGEN·Filed 1995·Granted Jun 16, 1998·1 cites·21 claims
- 4836US4873188AMethod, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodiesONCOGEN·Filed 1985·Granted Oct 10, 1989·5 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Karl E. Hellstrom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →